Lion TCR
Singapore - SingaporeBiotechnology
Focus: Lion TCR is a Singapore-based biotech company founded in 2021 specializing in T cell receptor (TCR) redirected T cell therapies for oncology and viral diseases. The company is at an early stage with a focused pipeline targeting hepatocellular carcinoma and chronic hepatitis B.
Profile data last refreshed 5h ago · AI intelligence enriched 2mo ago
Open Jobs
4+4 this month
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Should You Work at Lion TCR?
AI assessmentLion TCR presents a high-risk, high-reward early-stage opportunity suitable only for scientists comfortable with pre-clinical/clinical stage biotech volatility and willing to accept lower near-term financial certainty.
Why Work Here
- Ground-floor opportunity at a well-focused biotech with differentiated TCR platform technology in high-unmet-need oncology indications
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TCR redirected T cells
Hepatocellular CarcinomaClinical Trials (1)
NCT03899415TCR-Redirected T Cells Therapy in Patient With HBV Related HCC
Phase 1Help build intelligence for Lion TCR
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.